Archive for February 2022

Poor Medication Adherence: A Dangerous yet Modifiable Risk Factor in Psychiatry and Oncology Trials

When it comes to medication adherence in psychiatry and oncology trials, the stakes are high – not taking medicines as prescribed can have life-altering or even life-threatening consequences. As such, we often assume almost perfect adherence. Unfortunately, this could not be further from the truth.  The reality is that poor medication adherence is a universal…

Read More

When Participant Retention Diminishes, it’s Time to Invest in Participant Engagement

Boost clinical trial retention with participant engagement and adherence patterns Clinical trial participants are among a study’s most valuable assets – which is why Sponsors & CROs are increasingly investing to keep them on board, on track, and on the drug. Clinical trial participants are difficult, expensive, and time-consuming to recruit, yet dropout rates are…

Read More